Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) Return on Capital Employed [ROCE] (2023 - 2026)

Updated

Indivior Pharmaceuticals' Return on Capital Employed [ROCE] was 121.33% in Q2 2026, up 60.07 percentage points from 61.26% a year earlier and up 42.04 percentage points from the prior quarter.

Analysis

Supernus (INDV) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Indivior Pharmaceuticals came in at 76.05%, up 69.85 percentage points from FY2024.

  • In earlier years, Return on Capital Employed [ROCE] was 6.20% in FY2024.
  • Per Business Quant data, INDV's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 79.29% (Q1 2026), 66.41% (Q4 2025) and 48.40% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.33%
Mar 31, 2026 79.29%
Dec 31, 2025 66.41%
Sep 30, 2025 48.40%
Jun 30, 2025 61.26%
Mar 31, 2025 8.52%
Dec 31, 2024 8.15%
Dec 31, 2023 -0.95%
API Access

Supernus Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INDV&period=max&api_key=YOUR_API_KEY